Monterde, Presevinda C.
HRN: 17-33-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
CEFUROXIME 1.5GM (VIAL)
11/17/2025
11/24/2025
IV
1.5g
Q8h
CAP-MR
Waiting Final Action
11/17/2025
AZITHROMYCIN 500MG TABLET (TAB)
11/17/2025
11/21/2025
PO
500mg
Od
CAP-MR
Waiting Final Action
11/19/2025
CEFTAZIDIME 1GM (VIAL)
11/19/2025
11/26/2025
IV
2g
Q8
Urosepsis
Checking Initial Appropriateness